Magnus Financial Group LLC Corcept Therapeutics Inc Transaction History

Magnus Financial Group LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 05, 2020	SELL	$12.46 - $19.98 $125,285 - $200,898	-10,055 Closed	0 $0
Q2 2020 Aug 11, 2020	SELL	$11.0 - $18.26 $4,378 - $7,267	-398 Reduced 3.81%	10,055 $169,000
Q1 2020 May 11, 2020	BUY	$10.11 - $14.04 $105,679 - $146,760	10,453 New	10,453 $124,000
Q2 2019 Aug 05, 2019	SELL	$9.78 - $12.76 $108,636 - $141,738	-11,108 Closed	0 $0
Q1 2019 May 09, 2019	SELL	$10.03 - $15.71 $12,667 - $19,841	-1,263 Reduced 10.21%	11,108 $130,000
Q4 2018 Feb 13, 2019	BUY	$11.29 - $17.19 $139,668 - $212,657	12,371 New	12,371 $165,000

347

86.6M

1.12M

667K

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $6.39B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Magnus Financial Group LLC, based on Form 13F filings with the SEC.

Stay updated on Magnus Financial Group LLC with notifications on news.